fluorodeoxyglucose f18 has been researched along with arginyl-glycyl-aspartic acid in 20 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (25.00) | 29.6817 |
2010's | 14 (70.00) | 24.3611 |
2020's | 1 (5.00) | 2.80 |
Authors | Studies |
---|---|
Bading, JR; Bart, R; Bremner, R; Chen, X; Conti, PS; Hou, Y; Park, R; Sievers, E; Tohme, M | 1 |
Choe, YS; Choi, Y; Kim, BT; Ko, BH; Lee, KH; Paik, JY | 1 |
Beer, AJ; Goebel, M; Grosu, AL; Haubner, R; Luderschmidt, S; Martinez, MJ; Niemeyer, M; Schwaiger, M; Weber, WA; Wester, HJ; Wolf, I | 1 |
Cheng, Z; De, A; Gambhir, SS; Hoerner, JK; Levi, J; Namavari, M; Syud, FA; Yaghoubi, SS; Zhang, R | 1 |
Boerman, OC; Dijkgraaf, I | 1 |
Cao, Q; Chen, X; Liu, S; Neamati, N; Niu, G; Shen, B; Sun, X; Yan, Y; Yang, M | 1 |
Feng, J; Jia, HL; Li, HM; Li, XD; Zhang, JY | 1 |
Cameron, AG; Gao, X; Ke, S; Li, M; Lin, J; Qiu, X; Wang, W; Zhang, F; Zhu, VF; Zou, C | 1 |
Czarny, B; Dubois, A; Ducongé, F; Garofalakis, A; Tavitian, B; Thézé, B | 1 |
Cameron, AG; Gao, X; Ke, S; Li, M; Lin, J; Qiu, X; Wang, W; Yallampalli, S; Yu, D; Yustein, JT; Zhang, F; Zhang, S; Zou, C | 1 |
Dall'Angelo, S; Fleming, IN; O'Hagan, D; Piras, M; Schweiger, LF; Zanda, M; Zhang, Q | 1 |
Chang, E; Chin, FT; Dalman, RL; Gambhir, SS; James, ML; Kitagawa, T; Kosuge, H; McConnell, MV; Shen, B; Yamamoto, T | 1 |
Chen, X; Eden, HS; Guo, J; Guo, N; Kiesewetter, DO; Lang, L; Li, Q; Niu, G; Xie, Q | 1 |
Boersma, HH; de Haas, HJ; Dierckx, RA; Elsinga, PH; Glaudemans, AW; Golestani, R; Koole, M; Luurtsema, G; Mirfeizi, L; Slart, RH; Tio, RA; Westra, J; Zeebregts, CJ | 1 |
Fan, D; Jia, B; Liu, X; Liu, Z; Shi, J; Sun, Y; Wang, F; Zhang, X; Zhao, H; Zhong, L; Zhu, Z | 1 |
Ai, H; Chen, S; Cheng, Z; Jiang, X; Li, X; Lu, H; Qing, H; Wei, R; Wu, C; Xu, G | 1 |
Chang, JT; Chen, SH; Hsieh, CH; Kang, CJ; Liao, CT; Lin, CY; Wang, HM; Yang, LY; Yen, TC | 1 |
Jung, JH; Kim, SE; Lee, BC; Lee, MS; Park, HS; Yoo, JS | 1 |
Merabtene, F; Nataf, V; Prignon, A; Provost, C; Rozenblum-Beddok, L; Talbot, JN | 1 |
Balasse, L; Blot-Chabaud, M; Brige, P; Dignat-George, F; Fernandez, S; Garrigue, P; Guillet, B; Hache, G; Hubert, F; Moyon, A; Nail, V; Rochais, F | 1 |
1 review(s) available for fluorodeoxyglucose f18 and arginyl-glycyl-aspartic acid
Article | Year |
---|---|
Radionuclide imaging of tumor angiogenesis.
Topics: Alternative Splicing; Angiogenesis Inhibitors; Animals; Endothelium, Vascular; Fluorodeoxyglucose F18; Humans; Indium Radioisotopes; Integrin alphaVbeta3; Magnetic Resonance Imaging; Matrix Metalloproteinases; Mice; Neoplasm Metastasis; Neoplasms; Neoplasms, Experimental; Neovascularization, Pathologic; Oligopeptides; Positron-Emission Tomography; Receptors, Immunologic; Receptors, Peptide; Receptors, Vascular Endothelial Growth Factor | 2009 |
1 trial(s) available for fluorodeoxyglucose f18 and arginyl-glycyl-aspartic acid
Article | Year |
---|---|
RGD-K5 PET/CT in patients with advanced head and neck cancer treated with concurrent chemoradiotherapy: Results from a pilot study.
Topics: Adult; Chemoradiotherapy; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Integrin alphaVbeta3; Male; Middle Aged; Oligopeptides; Pilot Projects; Positron Emission Tomography Computed Tomography; Protein Transport | 2016 |
18 other study(ies) available for fluorodeoxyglucose f18 and arginyl-glycyl-aspartic acid
Article | Year |
---|---|
Integrin alpha v beta 3-targeted imaging of lung cancer.
Topics: Animals; Cell Adhesion; Chromatography, High Pressure Liquid; Copper; Dimerization; Dose-Response Relationship, Drug; Fluorodeoxyglucose F18; Humans; Integrin alphaVbeta3; Kinetics; Lung; Lung Neoplasms; Male; Mice; Mice, SCID; Microscopy, Fluorescence; Models, Chemical; Neoplasm Metastasis; Neoplasm Transplantation; Neovascularization, Pathologic; Oligopeptides; Peptides; Polyethylene Glycols; Positron-Emission Tomography; Protein Binding; Protein Structure, Tertiary; Radiopharmaceuticals; Time Factors | 2005 |
PMA-enhanced neutrophil [18F]FDG uptake is independent of integrin occupancy but requires PI3K activity.
Topics: Acridines; Androstadienes; Antineoplastic Agents; Carcinogens; Cells, Cultured; Fluorodeoxyglucose F18; Hexokinase; Humans; Integrins; Luminescent Measurements; Neutrophils; Oligopeptides; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase Inhibitors; Radiopharmaceuticals; Receptors, Immunologic; Respiratory Burst; Tetradecanoylphorbol Acetate; Tomography, Emission-Computed; Wortmannin | 2005 |
PET-based human dosimetry of 18F-galacto-RGD, a new radiotracer for imaging alpha v beta3 expression.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Integrin alphaVbeta3; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; Oligopeptides; Positron-Emission Tomography; Radiometry; Radiopharmaceuticals | 2006 |
A novel method for direct site-specific radiolabeling of peptides using [18F]FDG.
Topics: Animals; Cell Line, Tumor; Fluorodeoxyglucose F18; Humans; Integrin alphaVbeta3; Mice; Mice, Nude; Neoplasms; Oligopeptides; Positron-Emission Tomography; Radiopharmaceuticals | 2009 |
18F-FPPRGD2 and 18F-FDG PET of response to Abraxane therapy.
Topics: Albumin-Bound Paclitaxel; Albumins; Animals; Antineoplastic Agents; Cell Line, Tumor; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Integrin alphaVbeta3; Mammary Neoplasms, Experimental; Mice; Oligopeptides; Paclitaxel; Peptides, Cyclic; Positron-Emission Tomography; Radiopharmaceuticals; Xenograft Model Antitumor Assays | 2011 |
[Comparison of the biodistribution of four contrast agents in nude mice bearing NCI-H358 human lung cancer and evaluation of their value in diagnostic imaging].
Topics: Animals; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Oligopeptides; Organotechnetium Compounds; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Thiocarbamates; Tissue Distribution; Tomography, Emission-Computed, Single-Photon | 2011 |
Multiple target-specific molecular imaging agents detect liver cancer in a preclinical model.
Topics: Animals; Benzenesulfonates; Carbocyanines; Cell Line, Tumor; Fluorescent Dyes; Fluorodeoxyglucose F18; Humans; Indoles; Liver Neoplasms; Male; Matrix Metalloproteinases; Mice; Mice, Inbred C57BL; Microscopy, Confocal; Multimodal Imaging; Neoplasm Transplantation; Oligopeptides; Optical Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Single-Cell Analysis; Tissue Distribution; Tomography, X-Ray Computed | 2012 |
Fusion of [(18)F]FDG PET with fluorescence diffuse optical tomography to improve validation of probes and tumor imaging.
Topics: Animals; Cathepsins; Cell Line, Tumor; Diffusion; Fluorescent Dyes; Fluorodeoxyglucose F18; Humans; Mice; Molecular Probes; Neoplasms; Oligopeptides; Positron-Emission Tomography; Reproducibility of Results; Tissue Distribution; Tomography, Optical | 2013 |
Multiple target-specific molecular agents for detection and image analysis of breast cancer characteristics in mice.
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Mammary Neoplasms, Animal; Mice; Mice, Nude; Neoplasm Transplantation; Oligopeptides; Positron-Emission Tomography; Tomography, X-Ray Computed; Transplantation, Heterologous | 2013 |
Efficient bioconjugation of 5-fluoro-5-deoxy-ribose (FDR) to RGD peptides for positron emission tomography (PET) imaging of α(v)β(3) integrin receptor.
Topics: Cell Line, Tumor; Fluorodeoxyglucose F18; Humans; Integrin alphaVbeta3; Oligopeptides; Positron-Emission Tomography | 2013 |
Integrin-targeted molecular imaging of experimental abdominal aortic aneurysms by (18)F-labeled Arg-Gly-Asp positron-emission tomography.
Topics: Animals; Aortic Aneurysm, Abdominal; Diagnosis, Differential; Disease Models, Animal; Fluorodeoxyglucose F18; Immunohistochemistry; Integrin alphaVbeta3; Male; Mice; Molecular Imaging; Oligopeptides; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results | 2013 |
(18)F-alfatide II and (18)F-FDG dual-tracer dynamic PET for parametric, early prediction of tumor response to therapy.
Topics: Albumin-Bound Paclitaxel; Albumins; Animals; Antineoplastic Agents; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Mice; Mice, Nude; Neoplasms; Oligopeptides; Paclitaxel; Peptides, Cyclic; Positron-Emission Tomography; Radiopharmaceuticals; Time Factors | 2014 |
Feasibility of [18F]-RGD for ex vivo imaging of atherosclerosis in detection of αvβ3 integrin expression.
Topics: Aged; Aged, 80 and over; Biomarkers; Carotid Artery Diseases; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Integrin alphaVbeta3; Male; Middle Aged; Molecular Diagnostic Techniques; Molecular Imaging; Oligopeptides; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2015 |
(68)Ga-labeled 3PRGD2 for dual PET and Cerenkov luminescence imaging of orthotopic human glioblastoma.
Topics: Animals; Cell Line, Tumor; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Glioblastoma; Humans; Luminescence; Luminescent Measurements; Mice; Mice, Inbred BALB C; Oligopeptides; Optical Imaging; Organometallic Compounds; Peptides, Cyclic; Positron-Emission Tomography; Tissue Distribution | 2015 |
Ex-vivo biodistribution and micro-PET/CT imaging of 18F-FDG, 18F-FLT, 18F-FMISO, and 18F-AlF-NOTA-PRGD2 in a prostate tumor-bearing nude mouse model.
Topics: Animals; Cell Line, Tumor; Cell Transformation, Neoplastic; Dideoxynucleosides; Disease Models, Animal; Fluorodeoxyglucose F18; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Male; Mice; Mice, Nude; Misonidazole; Multimodal Imaging; Oligopeptides; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Tissue Distribution; Tomography, X-Ray Computed | 2015 |
Identification of Angiogenesis Rich-Viable Myocardium using RGD Dimer based SPECT after Myocardial Infarction.
Topics: Animals; Fluorodeoxyglucose F18; Integrin alphaVbeta3; Male; Myocardial Infarction; Myocardial Ischemia; Myocardium; Neovascularization, Pathologic; Oligopeptides; Organotechnetium Compounds; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Tomography, Emission-Computed, Single-Photon | 2016 |
[
Topics: Animals; Bevacizumab; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Fluorodeoxyglucose F18; Gallium Radioisotopes; Glioblastoma; Humans; Mice; Oligopeptides; Positron-Emission Tomography; Temozolomide; Tissue Distribution; Treatment Outcome; Tumor Burden | 2019 |
Comparison of a New
Topics: Animals; CD146 Antigen; Disease Models, Animal; Fibrosis; Fluorodeoxyglucose F18; Gallium Radioisotopes; Integrin alphaVbeta3; Male; Mice; Myocardial Infarction; Myocardium; Neovascularization, Pathologic; Oligopeptides; Positron-Emission Tomography; Radiopharmaceuticals | 2021 |